Business

Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call C...

articleCipher Pharmaceuticals Inc.November 3, 20203/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q3-2020-earnings-release-and-conference-call
Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call

About this update from Cipher Pharmaceuticals Inc.

[{"type":"text","content":"\n \n \n \n Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnsblb0{\nBORDER-LEFT:black 0pt\n}\n.prnvab{\nVERTICAL-ALIGN: BOTTOM\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnrbrb0{\nBORDER-RIGHT:black 0pt\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnsbtb0{\nBORDER-TOP:black 0pt\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n.prntal{\nTEXT-ALIGN: LEFT\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n OAKVILLE, ON, Nov. 3, 2020\n \n \n \n \n OAKVILLE, ON,\n \n Nov. 3, 2020\n \n /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (\"\n \n Cipher\n \n \" or \"the\n \n Company\n \n \") today announced it will release its Q3 2020 financial results after the close on\n \n Thursday, November 12\n \n , 2020.  The Company will hold a conference call on\n \n Friday, November 13, 2020\n \n to discuss the results.\n \n \n \n CONFERENCE CALL DETAILS\n \n \n \n \n \n \n \n \n DATE:\n \n \n \n \n \n \n Friday, November 13, 2020\n \n \n \n \n \n \n \n \n TIME:\n \n \n \n \n \n \n 8:30 a.m ET\n \n \n \n \n \n \n \n \n DIAL-IN:\n \n \n \n \n \n \n (416) 764-8688 or (888) 390-0546\n \n \n \n \n \n \n \n \n CONFERENCE ID:\n \n \n \n \n \n \n 46246305\n \n \n \n \n \n \n \n \n REPLAY DIAL-IN:\n \n \n \n \n \n \n 1 (888) 390-0541 (Playback 246305 #)\n \n \n \n \n \n \n \n \n Expires November 20, 2020\n \n \n \n \n \n \n \n \n Webcast:\n \n https://produceredition.webcasts.com/starthere.jsp?ei=1397006&tp_key=a8d3b9b5c2\n \n \n \n \n \n \n \n \n \n About Cipher Pharmaceuticals Inc.\n \n \n Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required ...

More updates from Cipher Pharmaceuticals Inc.